Found 33 matching trials
Management of Mixed-Phenotype Acute Leukemia in the East of France N/A Clinical presentation and management of Mixed-Phenotype Acute leukemia (MPA...
Show More Location
Multiple Locations
Learn More & Join Trial
Real World Asparaginase Therapy Toxicity N/A This research study is being done to learn more about the short term and lo...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia PHASE3 This study is a treatment protocol with blinatumomab for infants under 1 ye...
Show More Location
Hospital de Pediatría S.A.M.I.C. "Juan P. Garrahan"
Learn More & Join Trial
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia PHASE1 The purpose of this study is to determine the safety and tolerability of re...
Show More Location
University of California, San Francisco (UCSF) Benioff Children's Hospital
Learn More & Join Trial
Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) PHASE1 In this phase I study, escalating doses of IXAZOMIB will be combined with t...
Show More Location
Froedtert & the Medical College of Wisconsin
Learn More & Join Trial
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma PHASE4 The goal of this study is to provide sufficient therapy during the time a p...
Show More Location
Rady Children's Hospital
Learn More & Join Trial
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression PHASE2 Chimeric antigen receptor (CAR-T) engineered T cells against the CD19 prote...
Show More Location
Chaim Sheba Medical Center
Learn More & Join Trial
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy PHASE3 This phase III trial studies whether inotuzumab ozogamicin added to post-in...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) PHASE2 This is a clinical trial testing whether the addition of one of two chemoth...
Show More Location
Rady Children's Hospital
Learn More & Join Trial
Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation NA The purpose of this study is to assess the feasibility and acceptability of...
Show More Location
University of Kentucky
Learn More & Join Trial